Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Joseph Edelman, Perceptive Advisors Continue Bullish Streak in AcelRX Pharmaceuticals

Joseph Edelman’s fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position to over 6.57 million shares, after reporting buying a total of 515,700 shares last week. This time, Perceptive acquired 200,000 shares, the price varying around the $6.50 mark.

AcelRx Pharmaceuticals Inc

Disclosure: none

Recommended Reading:

Mario Gabelli, Gamco Disclose Moves Into Superior Industries International, Cutera and Bel Fuse

Why Did Brian Bares Significantly Cut His Stake in American Public Education?

Martin Whitman’s Third Avenue Cuts Exposure at Stanley Furniture

Loading...